clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Kidney Disease and Diabetes Increase Cardiovascular Disease Risk
News & Features
Even with Genetic Predisposition, Lifestyle Choices Impact Risk of Later Brain…
News & Features
GLP-1 and SGLT2 Drugs May Help Prevent Second Strokes and Heart…
News & Features
Lurie Children’s Developing Optical Genome Mapping Test for Brain Tumors
News & Features
Study Shines Light on Hereditary Back Issues
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Small Molecule Shows Promise for Alternative Sickle Cell Disease Treatment
Sickle cell disease
News & Features
Small Molecule Shows Promise for Alternative Sickle Cell Disease Treatment
August 1, 2024
0
News & Features
CRISPR Editing Strategy May Eliminate Toxic Conditioning for Cell Therapy
June 20, 2024
0
News & Features
CASGEVY Is Durable in over 100 Patients, Editas’ Reni-cel Shows Clinical Promise
June 17, 2024
0
News & Features
Can Gene Therapy Be Affordable? U.S. Tries New Access Model in Sickle Cell Disease
February 7, 2024
0
News & Features
In Another Win for CRISPR, FDA Approves Casgevy for Beta Thalassemia
January 17, 2024
0
News & Features
Two Gene Therapies for Sickle Cell Disease Get FDA Nod, Including First Ever CRISPR-Based Therapy
December 11, 2023
0
News & Features
U.K. Approves Vertex/CRISPR Tx’s Casgevy for Sickle Cell and Beta Thalassemia
November 16, 2023
0
News & Features
Base Editing Is Superior in Lab Test of Sickle Cell Disease Gene Therapy
July 5, 2023
0
News & Features
One and Done? How CRISPR Is Changing the Clinical Outlook for Multiple Diseases
Laura Cowen
June 5, 2023
0
News & Features
Bluebird Tightens Sickle Cell Race with BLA for Gene Therapy
April 25, 2023
0
1
2
3
Page 1 of 3
Related Content
Extrachromosomal DNA Spread Oncogenic Traits, Add Synthetic Lethal Targets
The End of the Beginning for Cell and Gene Therapy, Part 2
Behind the Breakthroughs: How to Turn $1,000,000 CAR Ts into “Real” Medicines
Lexeo Therapeutics Scores Positive Early Data for APOE4-Alzheimer’s Gene Therapy
Inside Precision Medicine